Getting GHK-Cu Dosing Right: A Step-by-Step Walkthrough

GHK-Cu at a glance:

• Drug class: Cosmetic peptide
• Route: topical for most; injectable melanotans are unlicensed
• Typical frequency: daily topical application typical
• Half-life: topical residence time varies

Here's the core rule for GHK-Cu dosing: titrate slowly, hold each step long enough, and don't try to outpace your body. Cosmetic peptides in skincare are regulated as cosmetics, not drugs.

Standard Dosing Schedule for GHK-Cu

Cosmetic peptides in skincare are regulated as cosmetics, not drugs. Injectable melanotans are not FDA-approved.

The typical schedule for GHK-Cu is daily topical application typical via topical for most; injectable melanotans are unlicensed. Half-life of topical residence time varies explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for GHK-Cu holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of GHK-Cu is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (topical residence time varies) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in GHK-Cu side effects and the cost angle of dose escalation in GHK-Cu cost.

What the Trials Used

Published clinical data on this compound is limited. Most reported dosing comes from observational or non-clinical sources.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For GHK-Cu: the standard contraindications for this drug class apply.

Bottom Line

GHK-Cu dosing isn't intuitive but it isn't complicated either. Follow the schedule, talk to your prescriber when something feels off, and don't make changes on your own.

Frequently Asked Questions

Related Reading

• The Honest Guide to GHK-Cu: What Patients and Doctors Actually Say
• GHK-Cu Side Effects: 7 Things to Watch For (and How to Manage Them)
• GHK-Cu Outcomes Decoded: Who Responds Best and Why
• How Much Does GHK-Cu Really Cost? The Honest Breakdown
• Melanotan II Explained: How It Works and Who It's For
• Melanotan II Side Effects in 2026: Real Reports, Real Solutions

Sources

• Habbema L et al. Risks of Unregulated Use of Alpha-Melanocyte-Stimulating Hormone Analogues. Br J Dermatol 2017;176:633.
• Pickart L. The Human Tri-Peptide GHK and Tissue Remodeling. J Biomater Sci Polym Ed 2008;19:969.

This page is informational only and is not medical advice. Always follow your prescribing clinician's dosing instructions.